Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGCETACOPLAN vs PEGFILGRASTIM-JMDB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEGCETACOPLAN vs PEGFILGRASTIM-JMDB: Safety Overview

Metric PEGCETACOPLAN PEGFILGRASTIM-JMDB
Total FAERS Reports 1,369 300
Deaths Reported 84 61
Death Rate 6.1% 20.3%
Hospitalizations 252 76
Average Patient Age 65.4 yrs 52.3 yrs
% Female Patients 70.5% 58.1%
FDA Approval Date Feb 17, 2023 N/A
Manufacturer Apellis Pharmaceuticals, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription Prescription